BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29870804)

  • 1. Cysteine cathepsins as a prospective target for anticancer therapies-current progress and prospects.
    Pogorzelska A; Żołnowska B; Bartoszewski R
    Biochimie; 2018 Aug; 151():85-106. PubMed ID: 29870804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cysteine cathepsins and cystatins: from ancillary tasks to prominent status in lung diseases.
    Lalmanach G; Saidi A; Marchand-Adam S; Lecaille F; Kasabova M
    Biol Chem; 2015 Feb; 396(2):111-30. PubMed ID: 25178906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cathepsins: Potent regulators in carcinogenesis.
    Khaket TP; Kwon TK; Kang SC
    Pharmacol Ther; 2019 Jun; 198():1-19. PubMed ID: 30763594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cysteine cathepsin proteases as pharmacological targets in cancer.
    Palermo C; Joyce JA
    Trends Pharmacol Sci; 2008 Jan; 29(1):22-8. PubMed ID: 18037508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cysteine Cathepsins: Potential Applications in Diagnostics and Therapy of Malignant Tumors.
    Petushkova AI; Savvateeva LV; Korolev DO; Zamyatnin AA
    Biochemistry (Mosc); 2019 Jul; 84(7):746-761. PubMed ID: 31509726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response.
    Olson OC; Joyce JA
    Nat Rev Cancer; 2015 Dec; 15(12):712-29. PubMed ID: 26597527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple roles for cysteine cathepsins in cancer.
    Joyce JA; Hanahan D
    Cell Cycle; 2004 Dec; 3(12):1516-619. PubMed ID: 15539953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cysteine cathepsins: Their biological and molecular significance in cancer stem cells.
    Pišlar A; Jewett A; Kos J
    Semin Cancer Biol; 2018 Dec; 53():168-177. PubMed ID: 30063965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cysteine cathepsins: structure, physiological functions and their role in carcinogenesis].
    Gureeva TA; Timoshenko OS; Kugaevskaya EV; Solovyova NI
    Biomed Khim; 2021 Nov; 67(6):453-464. PubMed ID: 34964439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cysteine cathepsins: multifunctional enzymes in cancer.
    Mohamed MM; Sloane BF
    Nat Rev Cancer; 2006 Oct; 6(10):764-75. PubMed ID: 16990854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cathepsins and pancreatic cancer: the 2012 update.
    Sulpizio S; Franceschini N; Piattelli A; Di Sebastiano P; Innocenti P; Selvaggi F
    Pancreatology; 2012; 12(5):395-401. PubMed ID: 23127526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The current stage of cathepsin B inhibitors as potential anticancer agents.
    Kos J; Mitrović A; Mirković B
    Future Med Chem; 2014 Jul; 6(11):1355-71. PubMed ID: 25163003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Cysteine Cathepsins in Cancer Progression and Drug Resistance.
    Rudzińska M; Parodi A; Soond SM; Vinarov AZ; Korolev DO; Morozov AO; Daglioglu C; Tutar Y; Zamyatnin AA
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31340550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cysteine cathepsin activity suppresses osteoclastogenesis of myeloid-derived suppressor cells in breast cancer.
    Edgington-Mitchell LE; Rautela J; Duivenvoorden HM; Jayatilleke KM; van der Linden WA; Verdoes M; Bogyo M; Parker BS
    Oncotarget; 2015 Sep; 6(29):27008-22. PubMed ID: 26308073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cysteine proteinases in cancer progression and their clinical relevance for prognosis.
    Lah TT; Kos J
    Biol Chem; 1998 Feb; 379(2):125-30. PubMed ID: 9524063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-distribution of cysteine cathepsins and matrix metalloproteases in human dentin.
    Scaffa PM; Breschi L; Mazzoni A; Vidal CM; Curci R; Apolonio F; Gobbi P; Pashley D; Tjäderhane L; Tersariol IL; Nascimento FD; Carrilho MR
    Arch Oral Biol; 2017 Feb; 74():101-107. PubMed ID: 27923176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitors of proteases as anticancer drugs.
    Jedinak A; Maliar T
    Neoplasma; 2005; 52(3):185-92. PubMed ID: 15875078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The regulation of cysteine cathepsins and cystatins in human gliomas.
    Gole B; Huszthy PC; Popović M; Jeruc J; Ardebili YS; Bjerkvig R; Lah TT
    Int J Cancer; 2012 Oct; 131(8):1779-89. PubMed ID: 22287159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor cell- and microenvironment-specific roles of cysteine cathepsins in mouse models of human cancers.
    Hölzen L; Parigiani MA; Reinheckel T
    Biochim Biophys Acta Proteins Proteom; 2020 Jul; 1868(7):140423. PubMed ID: 32247787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cysteine cathepsins and their potential in clinical therapy and biomarker discovery.
    Fonović M; Turk B
    Proteomics Clin Appl; 2014 Jun; 8(5-6):416-26. PubMed ID: 24470315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.